References
- Prada J, Shalapour S, Pfau M, et al. Antiproliferative effect of the serotonin receptor antagonist ondansetron in the acute lymphoblastic leukemia cell line REH. Acta Oncol 2011;50: 591–592.
- Holdsworth MT, Raisch DW, Winter SS, et al. Assessment of the emetogenic potencial of intrathecal chemotherapy and response to prophylactic treatment with ondansetron. Support Care Cancer 1998;6:132–138.
- Prada J, Shalapour S, Pfau M, et al. The serotonin receptor-antagonist ondansetron induces significant increases in the expression of interferon-gamma which correlate with antiproliferative properties in the acute lymphoblastic leukaemia cell line REH. Scand J Immunol 2012;76:519–520.
- Prada J, Shalapour S, Pfau M, et al. Antiproliferative properties of the serotonin receptor antagonist ondansetron correlate with increased nitric oxides release and inducible nitric oxide synthase activity in the acute lymphoblastic leukemia cell line REH. Eur J Inflamm 2012;10:531–534.
- Matsuo Y, Drexler HG. Establishment and characterization of human B cell precursor-leukemia cell lines. Leukemia Res 1998;22: 567–579.
- Tsuzuki S, Karnan S, Horibe K, et al. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization. Cancer Sci 2007;98:698–706.
- Prada J, Ngo-Tu T, Baatz H, et al. Detection of tumor necrosis factor alpha and interleukin-1 alpha gene expression in human lens epithelial cells. J Cataract Refr Surg 2000;26:114–117.
- Veltri S, Smith JW II. Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects. Stem Cells 1996;14:164–176.
- Guo L, Ye C, Chen W, et al. Anti-inflammatory and analgesic potency of carboxyamidotriazole, a tumorostatic agent. J Pharmacol Exp Ther 2008;325:10–16.
- Beaupre DM, Talpaz M, Marini FC III, et al. Autocrine interleukin-1β production in leukemia: evidence for the involvement of mutated RAS. Cancer Res 1999;59:2971–2980.
- Das L, Vinayak M. Curcumin attenuates carcinogenesis by down regulating proinflammatory cytokine interleukin-1 (IL-1α and IL-1β) via modulation of AP-1 and NF-IL6 in lymphoma bearing mice. Int Immunopharmacol 2014;20:141–147.
- Hoffmann J, Junker H, Schmieder A, et al. EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells. Biochem Pharmacol 2011;82:1153–1162.
- Jaganathan SK, Supriyanto E. Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells. Molecules 2012;17:6290–6304.
- Estrov Z, Shishodia S, Faderl S, et al. Resveratrol blocks interleukin-1 beta-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003;102: 987–995.
- Tejeda M, Gaal D, Csuka O, et al. Growth inhibitory effect of the somatostatin structural derivative TT-232 on leukemia models. Anticancer Res 2005;25:325–330.